Bay Area Equity Fund

The Bay Area Equity Fund is a venture capital fund that pioneered the "double bottom line" investment model, which seeks to generate market-rate financial returns while also achieving positive social and environmental impact. Originally launched in 2004 and managed by JPMorgan, the fund was later spun off to form DBL Partners, a leading impact investing firm. The fund focuses on high-growth sectors including life sciences, healthcare, clean technology, and information technology, with a specific geographic emphasis on the San Francisco Bay Area. Its portfolio has included significant healthcare and biotechnology companies such as FivePrime Therapeutics, Labcyte, and Everyday Health. By investing in companies that provide community benefits and economic development, the fund aims to support sustainable growth in underserved neighborhoods.